Current Protein Identity：P00323
New Search
Difference tags compare only the current result set; every original PDB and assembly record remains separate.
Related-Structure Differences
Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.
| PDB Entry | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Experimental Method | Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1AKQ D95A OXIDIZED FLAVODOXIN MUTANT FROM D. VULGARIS Deposited 1997-03-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：D95A | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 7；PROTEIN WAS CRYSTALLIZED FROM 60-70% A.S., 100MM TRIS-HCL, PH=7.0.
|
Resolution 1.90 Å R-free 0.240 |
| 1AKR G61A OXIDIZED FLAVODOXIN MUTANT Deposited 1997-05-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：G61A | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 7；60-70% AMMONIUM SULFATE, 100MM TRIS-HCL, pH 7.0
|
Resolution 1.58 Å |
| 1AKT G61N OXIDIZED FLAVODOXIN MUTANT Deposited 1997-05-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：G61N | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 7；60-70% AMMONIUM SULFATE, 100MM TRIS-HCL, pH 7.0
|
Resolution 1.80 Å |
| 1AKU D95A HYDROQUINONE FLAVODOXIN MUTANT FROM D. VULGARIS Deposited 1997-05-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：D95A | SO4 SULFATE ION × 2 FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 7；60-70% AMMONIUM SULFATE, 100MM TRIS-HCL, PH=7.0.
|
Resolution 1.90 Å R-free 0.270 |
| 1AKV D95A SEMIQUINONE FLAVODOXIN MUTANT FROM D. VULGARIS Deposited 1997-05-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：D95A | SO4 SULFATE ION × 4 FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 7；60-70% AMMONIUM SULFATE, 100MM TRIS-HCL, PH=7.0.
|
Resolution 2.00 Å R-free 0.250 |
| 1AKW G61L OXIDIZED FLAVODOXIN MUTANT Deposited 1997-05-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：G61L | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 7；60-70% AMMONIUM SULFATE, 100MM TRIS-HCL, pH 7.0
|
Resolution 1.75 Å R-free 0.194 |
| 1AZL G61V FLAVODOXIN MUTANT FROM DESULFOVIBRIO VULGARIS Deposited 1997-11-18 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：G61V | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
macroseeding；pH 7；PROTEIN SEED CRYSTALS WERE OBTAINED FROM 60-70% AMMONIUM SULFATE, 10MM TRIS PH 7.0, 1-2% ACETONE. MACROSEEDS WERE TRANSFERRED TO THE ABOVE SOLUTION WITH NO ACETONE PRESENT., macroseeding
|
Resolution 1.80 Å |
| 1BU5 X-RAY CRYSTAL STRUCTURE OF THE DESULFOVIBRIO VULGARIS (HILDENBOROUGH) APOFLAVODOXIN-RIBOFLAVIN COMPLEX Deposited 1998-09-12 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain not uniquely mapped
Reference range not declared
Chain A
2–148（147 aa）
|
Not recorded | SO4 SULFATE ION × 2 RBF RIBOFLAVIN × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 7；CRYSTALS WERE GROWN USING THE HANGING DROP METHOD OF VAPOUR DIFFUSION FROM
TRIALS WITH AMMONIUM SULPHATE IN THE CONCENTRATION RANGE 60-80% SATURATION IN
50MM SODIUM PHOSPHATE BUFFER PH 8.0 CONTAINING 1MM EDTA WITH A PROTEIN
CONCENTRATION OF 10-15MG/ML. CRYSTALS APPEAR OVER 1-3 DAYS., pH 7.0
|
Resolution 1.83 Å R-free 0.202 |
| 1C7E D95E HYDROQUINONE FLAVODOXIN MUTANT FROM D. VULGARIS Deposited 2000-02-16 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：D95E | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 8.5；70-73% A.S., 210MM TRIS-HCL, 200MM SODIUM ACETATE PH=8.5
|
Resolution 2.25 Å R-free 0.297 |
| 1C7E D95E HYDROQUINONE FLAVODOXIN MUTANT FROM D. VULGARIS Deposited 2000-02-16 | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain B
2–148（147 aa）
|
Mutation：D95E | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 8.5；70-73% A.S., 210MM TRIS-HCL, 200MM SODIUM ACETATE PH=8.5
|
Resolution 2.25 Å R-free 0.297 |
| 1C7F D95E OXIDIZED FLAVODOXIN MUTANT FROM D. VULGARIS Deposited 2000-02-11 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：YES | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 6.5；70-70% A.S. 210MM TRIS-HCL PH=6.5, 200MM SODIUM ACETATE
|
Resolution 2.00 Å R-free 0.240 |
| 1C7F D95E OXIDIZED FLAVODOXIN MUTANT FROM D. VULGARIS Deposited 2000-02-11 | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain B
2–148（147 aa）
|
Mutation：YES | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 6.5；70-70% A.S. 210MM TRIS-HCL PH=6.5, 200MM SODIUM ACETATE
|
Resolution 2.00 Å R-free 0.240 |
| 1F4P Y98W FLAVODOXIN MUTANT 1.5A (D. VULGARIS) Deposited 2000-06-08 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：Y98W | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7.3；292 K；Ammonium Sulfate, Tris Buffer, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 292.K
|
Resolution 1.30 Å R-free 0.169 |
| 1FX1 A CRYSTALLOGRAPHIC STRUCTURAL STUDY OF THE OXIDATION STATES OF DESULFOVIBRIO VULGARIS FLAVODOXIN Deposited 1984-10-15 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
1–148（148 aa）
|
Not recorded | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 2.00 Å |
| 1I1O ROOM TEMPERATURE CRYSTAL STRUCTURE FLAVODOXIN D. VULGARIS MUTANT Y98H AT 2.0 ANG. RESOLUTION Deposited 2001-02-02 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
Fragment：MAIN CHAIN
|
Mutation：Y98H | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7.3；293 K；3.2 M Ammonium Sulfate, Tris.buffer, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.00 Å |
| 1J8Q Low Temperature (100K) Crystal Structure of Flavodoxin D. vulgaris Wild-type at 1.35 Angstrom Resolution Deposited 2001-05-22 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Not recorded | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；295 K；Ammonium Sulphate, Tris HCl Buffer, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 1.35 Å R-free 0.181 |
| 1J9E Low Temperature (100K) Crystal Structure of Flavodoxin D. vulgaris S35C Mutant at 1.44 Angstrom Resolution Deposited 2001-05-25 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：S35C | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；295 K；Ammonium sulphate, tris-HCl buffer, pH 7.00, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 1.44 Å R-free 0.156 |
| 1J9G Low Temperature (100K) Crystal Structure of Flavodoxin D. vulgaris S64C Mutant, monomer oxidised, at 2.4 Angstrom Resolution Deposited 2001-05-25 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：S64C | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；295 K；Ammonium Sulphate, Tris HCl Buffer, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.40 Å R-free 0.247 |
| 1WSB Flavodoxin mutant- S64C Deposited 2004-11-05 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
1–148（148 aa）
|
Mutation：S64C | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；298 K；temperature 298K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.80 Å R-free 0.249 |
| 1WSW Low Temperature (100K) Crystal Structure Of Flavodoxin Mutant S64C, dimer, semiquinone state Deposited 2004-11-12 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
1–148（148 aa）
|
Mutation：S64C | FMN FLAVIN MONONUCLEOTIDE × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；298 K；Ammonium Sulphate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.69 Å R-free 0.245 |
| 1XT6 S35C Flavodoxin Mutant in the semiquinone state Deposited 2004-10-21 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：S35C | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
sitting drop, vapor diffusion；pH 7；298 K；3.2M ammonium sulfate, pH 7, sitting drop, vapor diffusion, temperature 298K
|
Resolution 1.80 Å R-free 0.261 |
| 1XYV Low Temperature (100K) Crystal Structure Of Flavodoxin Mutant S64C, monomer, semiquinone state Deposited 2004-11-11 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
1–148（148 aa）
|
Mutation：S64C | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；298 K；Ammonium Sulphate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.79 Å R-free 0.237 |
| 1XYY Low Temperature (100K) Crystal Structure Of Flavodoxin Mutant S64C, homodimer, oxidised state Deposited 2004-11-11 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
1–148（148 aa）
|
Mutation：S64C | FMN FLAVIN MONONUCLEOTIDE × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；298 K；Ammonium Sulphate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.70 Å R-free 0.253 |
| 2FX2 COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES Deposited 1991-10-17 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Not recorded | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 1.90 Å |
| 3FX2 COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES Deposited 1991-10-17 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Not recorded | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 1.90 Å |
| 4FX2 COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES Deposited 1991-10-17 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Not recorded | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 1.90 Å |
| 5FX2 COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES Deposited 1991-10-17 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Not recorded | FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 1.90 Å |
| 5TGZ Crystal Structure of the Human Cannabinoid Receptor CB1 Deposited 2016-09-28 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
Fragment：UNP RESIDUES 99-306,UNP RESIDUES 2-148,UNP RESIDUES 332-414
|
Mutation：T210A, E273K, T283V,P1002A, Y1098W,R340E | ZDG 4-[4-[2-(2,4-dichlorophenyl)-4-methyl-5-(piperidin-1-ylcarbamoyl)pyrazol-3-yl]phenyl]but-3-ynyl nitrate × 1 FMN FLAVIN MONONUCLEOTIDE × 1 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1 OLA OLEIC ACID × 3 PEG DI(HYDROXYETHYL)ETHER × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；293 K；0.1M HEPES pH 7.0-7.4, 100mM (NH4)2HPO4, 25%-32% PEG 400, 2-20 mM Ethylenediaminetetraacetic acid disodium salt dehydrate (EDTA)
|
Resolution 2.80 Å R-free 0.238 |
| 5V56 2.9A XFEL structure of the multi-domain human smoothened receptor (with E194M mutation) in complex with TC114 Deposited 2017-03-13 | Assembly 1 Insufficient information Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
2–148（147 aa）
Fragment：UNP RESIDUES 53-433,444-558
Chain B
2–148（147 aa）
Fragment：UNP RESIDUES 53-433,444-558
|
Mutation：E194E, P2A, Y98W Mutation：E194E, P2A, Y98W | 836 N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-4-nitro-2-(trifluoromethyl)benzamide × 2 FMN FLAVIN MONONUCLEOTIDE × 2 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；293 K；100 mM Sodium citrate tribasic dihydrate pH 5.0, 36% (v/v) PEG400, 50-200 mM Ammonium nitrate
|
Resolution 2.90 Å R-free 0.239 |
| 5V57 3.0A SYN structure of the multi-domain human smoothened receptor in complex with TC114 Deposited 2017-03-13 | Assembly 1 Insufficient information Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
2–148（147 aa）
Fragment：UNP RESIDUES 58-433,444-558
Chain B
2–148（147 aa）
Fragment：UNP RESIDUES 58-433,444-558
|
Mutation：P2A, Y98W Mutation：P2A, Y98W | 836 N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-4-nitro-2-(trifluoromethyl)benzamide × 2 FMN FLAVIN MONONUCLEOTIDE × 2 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 5；293 K；100 mM Sodium citrate tribasic dihydrate pH 5.0, 36% (v/v) PEG 400, 50-200 mM Ammonium nitrate
|
Resolution 3.00 Å R-free 0.240 |
| 5XR8 Crystal structure of the human CB1 in complex with agonist AM841 Deposited 2017-06-07 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
Fragment：;UNP residues 99-306,UNP residues 3-148,UNP residues 332-414,UNP residues 99-306,UNP residues 3-148,UNP residues 332-414,UNP residues 99-306,UNP residues 3-148,UNP residues 332-414
;
|
Mutation：T210A,E273K,T283V,Y1098W,R340E | FMN FLAVIN MONONUCLEOTIDE × 1 8D0 (6~{a}~{R},9~{R},10~{a}~{R})-9-(hydroxymethyl)-3-(8-isothiocyanato-2-methyl-octan-2-yl)-6,6-dimethyl-6~{a},7,8,9,10,10~{a}-hexahydrobenzo[c]chromen-1-ol × 1 CLR CHOLESTEROL × 1 PEG DI(HYDROXYETHYL)ETHER × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.2；293 K；0.1 M sodium cacodylate trihydrate pH 6.2, 120 mM C6H5Na3O7, 30% PEG400 and 100 mM Glycine
|
Resolution 2.95 Å R-free 0.274 |
| 5XRA Crystal structure of the human CB1 in complex with agonist AM11542 Deposited 2017-06-08 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
Fragment：UNP residues 99-306,UNP residues 3-148,UNP residues 332-414
|
Mutation：T210A, E273K, T283V,Y1098W,R340E | FMN FLAVIN MONONUCLEOTIDE × 1 8D3 (6aR,10aR)-3-(8-bromanyl-2-methyl-octan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol × 1 OLA OLEIC ACID × 2 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2 PEG DI(HYDROXYETHYL)ETHER × 1 CLR CHOLESTEROL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；293 K；0.1 M sodium cacodylate trihydrate pH 6.4, 300-350 mM C4H4KNaO6, 30% PEG400
|
Resolution 2.80 Å R-free 0.252 |
| 5YOB Crystal Structure of flavodoxin without engineered disulfide bond Deposited 2017-10-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Mutation：Y98W | FMN FLAVIN MONONUCLEOTIDE × 1 GOL GLYCEROL × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；293 K；Tris-HCL 0.1M
Ammonium Sulfate 3.2M
|
Resolution 1.14 Å R-free 0.177 |
| 5YOC Crystal Structure of flavodoxin with engineered disulfide bond C102-R125C Deposited 2017-10-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Mutation：R125C, Y98W | FMN FLAVIN MONONUCLEOTIDE × 1 GOL GLYCEROL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；293 K；Tris-HCL 0.1M
Ammonium Sulfa 3.1M
|
Resolution 1.50 Å R-free 0.192 |
| 5YOE Crystal Structure of flavodoxin with engineered disulfide bond A43C-L74C Deposited 2017-10-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Mutation：A43C, L74C, Y98W | FMN FLAVIN MONONUCLEOTIDE × 1 GOL GLYCEROL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；293 K；Tris-HCL 0.1M
Ammonium Sulfate 3.2M
|
Resolution 1.35 Å R-free 0.181 |
| 5YOG Crystal Structure of flavodoxin with engineered disulfide bond N14C-C93 Deposited 2017-10-27 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Mutation：N14C, Y98W | FMN FLAVIN MONONUCLEOTIDE × 1 GOL GLYCEROL × 2 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7.3；293 K；Tris-HCL buffer, pH 7.3
Ammonium Sulfate 3.1M
|
Resolution 1.42 Å R-free 0.180 |
| 5ZKP Crystal structure of the human platelet-activating factor receptor in complex with SR 27417 Deposited 2018-03-25 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Mutation：F116Y, N169D,P2A, Y98W,A230D, V234A, D289N | 9ER N1,N1-dimethyl-N2-[(pyridin-3-yl)methyl]-N2-{4-[2,4,6-tri(propan-2-yl)phenyl]-1,3-thiazol-2-yl}ethane-1,2-diamine × 1 FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；293 K；HEPES, PEG 400, NaSCN, Na citrate
|
Resolution 2.81 Å R-free 0.259 |
| 6LI0 Crystal structure of GPR52 in complex with agonist c17 Deposited 2019-12-10 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Mutation：A130W,Y1098W,A264L,W278Q,C314P,S318A,N321D,V323T | EN6 N-(2-hydroxyethyl)-5-(hydroxymethyl)-3-methyl-1-[2-[[3-(trifluoromethyl)phenyl]methyl]-1-benzothiophen-7-yl]pyrazole-4-carboxamide × 1 FMN FLAVIN MONONUCLEOTIDE × 1 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 17 PEG DI(HYDROXYETHYL)ETHER × 8 FLC CITRATE ANION × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 5；293 K；0.13-0.18 M sodium acetate,
0.1 M sodium citrate PH5.0,
32-35% PEG400
|
Resolution 2.20 Å R-free 0.220 |
| 6LI1 Crystal structure of GPR52 ligand free form with flavodoxin fusion Deposited 2019-12-10 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Mutation：A130W,Y1098W,W278Q,C314P,S318A,N321D,V323T | OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2 FMN FLAVIN MONONUCLEOTIDE × 1 PEG DI(HYDROXYETHYL)ETHER × 1 PGE TRIETHYLENE GLYCOL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 5；293 K；0.1 M potassium acetate, 0.1 M sodium citrate pH 5.0, and 30% PEG400
|
Resolution 2.90 Å R-free 0.267 |
| 7DDZ The Crystal Structure of Human Neuropeptide Y Y2 Receptor with JNJ-31020028 Deposited 2020-10-30 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Not recorded | H46 ~{N}-[4-[4-[(1~{S})-2-(diethylamino)-2-oxidanylidene-1-phenyl-ethyl]piperazin-1-yl]-3-fluoranyl-phenyl]-2-pyridin-3-yl-benzamide × 1 FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；293.15 K；0.1 M HEPES, pH 7.0-7.5, 250-350 mM (NH4)2SO4, and 20-30% PEG500DME, or 0.1 M MES, pH 6.0-6.5, 380-420 mM NH4 tartrate, and 24-26% PEG500DME
|
Resolution 2.80 Å R-free 0.289 |
| 7K15 Crystal structure of the Human Leukotriene B4 Receptor 1 in Complex with Selective Antagonist MK-D-046 Deposited 2020-09-07 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
2–148（147 aa）
|
Not recorded | VRJ N-(tert-butylsulfonyl)-4-fluoro-2-{(3S,4R)-4-hydroxy-3-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1-benzopyran-7-yl}benzamide × 1 NA SODIUM ION × 1 FMN FLAVIN MONONUCLEOTIDE × 1 OLA OLEIC ACID × 1 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2 1PE PENTAETHYLENE GLYCOL × 1 2PE NONAETHYLENE GLYCOL × 1 P6G HEXAETHYLENE GLYCOL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 5.8；293 K；sodium citrate tribasic dihydrate pH 5.8, sodium acetate trihydrate, benzamidine hydrochloride, PEG-400, MK-D-046, DMSO
|
Resolution 2.88 Å R-free 0.261 |
| 7V3Z Structure of cannabinoid receptor type 1(CB1) Deposited 2021-08-12 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–148（146 aa）
|
Mutation：H154L,T210A,E273K,T283V,Y1098W,R340E | 9GF 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol × 1 CLR CHOLESTEROL × 1 FMN FLAVIN MONONUCLEOTIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 7.2；293.15 K；30% PEG400, 100 mM HEPES sodium pH 7.2, 80-100mM sodium citrate tribasic dihydrate
|
Resolution 3.29 Å R-free 0.276 |